Unibest
← Back to patent-cliff list

CAS 1448869-68-8

ethyl 2-bromo-5-((4-chlorophenyl)(hydroxy)methyl)-1-isopropyl-1H-imidazole-4-carboxylate

Codes: HDM-201-007

Application context (from source-drug indications)

SarcomaSiremadlinHaematological malignancySiremadlinHepatic function declineSiremadlinAcute myeloid leukaemiaSiremadlinColorectal cancerSiremadlinMetastatic cancerSiremadlin

Source drugs (routes using this intermediate)

DrugTierExpiry
SiremadlinTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.